Clinical Trial Update: A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea

View source ↗

Summary

Pfizer is conducting a post-market study in Korea to gather information about Zavicefta (ceftazidime-avibactam) after it was released, covering several serious …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Complicated Urinary Tract Infection
• Hospital-acquired Pneumonia

Drugs mentioned

• Zavicefta (ceftazidime-avibactam)

Snippet

Sponsor: Pfizer | Conditions: Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection | Status: RECRUITING